Georges Gemayel joins NPS Pharmaceuticals board
This article was originally published in Scrip
Executive Summary
NPS Pharmaceuticals, a biopharmaceutical company developing orphan products for rare disorders, has appointed Dr Georges Gemayel to its board of directors. Dr Gemayel previously served as chair of FoldRx Pharmaceuticals, as well as president and CEO of Altus Pharmaceuticals from 2008-09. Prior to Altus, he was an executive vice-president of Genzyme.